Fragments of alpha-1-antitrypsin in patients with severe COVID-19 and bacterial pulmonary sepsis
- PMID: 35503554
- DOI: 10.1515/cclm-2022-0361
Fragments of alpha-1-antitrypsin in patients with severe COVID-19 and bacterial pulmonary sepsis
Keywords: COVID; alpha-1-antitrypsin; inflammation; proteases.
Comment on
-
Protease-antiprotease imbalance in patients with severe COVID-19.Clin Chem Lab Med. 2021 Mar 8;59(8):e330-e334. doi: 10.1515/cclm-2021-0137. Print 2021 Jul 27. Clin Chem Lab Med. 2021. PMID: 33675194 No abstract available.
References
-
- Zerimech, F, Jourdain, M, Onraed, B, Bouchecareilh, M, Sendid, B, Duhamel, A, et al.. Protease-antiprotease imbalance in patients with severe COVID-19. Clin Chem Lab Med 2021;59:e330–4. https://doi.org/10.1515/cclm-2021-0137.
-
- Vianello, A, Braccioni, F. Geographical overlap between alpha-1 antitrypsin deficiency and COVID-19 infection in Italy: casual or causal? Arch Bronconeumol 2020;56:609–10. https://doi.org/10.1016/j.arbres.2020.05.015.
-
- Ritzmann, F, Chitirala, P, Krüger, N, Hoffmann, M, Zuo, W, Lammert, F, et al.. Therapeutic application of alpha-1 antitrypsin in COVID-19. Am J Respir Crit Care Med 2021;204:224–7. https://doi.org/10.1164/rccm.202104-0833LE.
-
- McElvaney, OJ, McEvoy, NL, McElvaney, OF, Carroll, TP, Murphy, MP, Dunlea, DM, et al.. Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med 2020;202:812–21. https://doi.org/10.1164/rccm.202005-1583oc.
-
- McKelvey, MC, Brown, R, Ryan, S, Mall, MA, Weldon, S, Taggart, CC. Proteases, mucus, and mucosal immunity in chronic lung disease. Int J Mol Sci 2021;22:5018. https://doi.org/10.3390/ijms22095018.